Key result
Blood viscosity correlates with all cardiovascular risk factors and decreases with their treatment.
Why the study?
Does the measurement of blood viscosity help guide the treatment of cardiovascular disease risk?
Does the measurement of blood viscosity help guide the treatment of cardiovascular disease risk?
Blood viscosity is proposed as a unifying biomarker for cardiovascular disease risk that could potentially help guide treatment.
Blood viscosity measurement should not yet guide cardiovascular risk management; hypothesis-generating as a unifying biomarker pending prospective trials.
• Blood viscosity is associated with all know cardiovascular risk factors. • The treatment of all known cardiovascular risk factors also decreases blood viscosity. • The measurement of blood viscosity may help to guide the treatment of cardiovascular disease risk.
No takes yet. Share an insight, caveat, or question.
Erik Finlayson (2026) studied this question. Blood viscosity is associated with all known cardiovascular risk factors, and treating these factors decreases viscosity, suggesting its measurement may guide cardiovascular risk management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: